Additional file 1 of Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study

Authors :: Huiqiang Huang
Zhu, Jun
Yao, Ming
Kim, Tae Min
Yoon, Dok Hyun
Seok-Goo Cho
Eom, Hyeon Seok
Lim, Soon Thye
Su-Peng Yeh
Yuqin Song
Yok Lam Kwong
Kim, Jin Seok
Jin, Jie
Yuankai Shi
Kim, HyeJin
Qing, Min
Tianyuan Zhou
Gao, Grace
Zongqi Dong
Qi, Ming
Kim, Won Seog
Publication Year :: 2021
Publisher :: figshare, 2021.
Abstract: Additional file 1: Supplementary methods and results.

Full Text Access

Tools